The Punjab government has implemented a two-week ban on the sale and usage of a locally manufactured injection that is allegedly causing loss of vision in patients. The ban will remain in place until quality check results are obtained.
A committee has been formed, led by King Edward Medical University’s Dr Asad Aslam Khan, to investigate the cases of blindness that have been reported after the administration of the injection “Avastin” in various hospitals across the province. The committee consists of experts from the medical field.
Several patients in Lahore, Kasur, and Jhang districts were given Avastin injections for retinal damage caused by diabetes. However, these injections resulted in severe infections, leading to the loss of eyesight in approximately 12 patients. One of the patients affected is the brother of senior PPP leader Chaudhry Manzoor, along with his friend.
Punjab’s caretaker Chief Minister, Mohsin Naqvi, has announced that the government will provide free treatment to all the affected patients. A high-powered inquiry team has also been established to ensure a swift investigation into the matter. Naqvi has further instructed the police to arrest those responsible for this incident.
The recalled injection has been removed from the market, and a case has been registered against the suppliers. Caretaker Health Minister Dr Nadeem Jan has assured the public that a transparent investigation will take place, with the findings being shared with the people. The government will take legal action against those responsible and provide support and medical attention to the affected patients.
According to Punjab Minister for Primary and Secondary Healthcare Dr Jamal Nasir, the injection in question was earning a significant profit. It was manufactured by a multinational pharmaceutical company and distributed by a reputable institution. The entire batch has been removed from the market by the Drug Regulatory Authority of Pakistan (Drap), and strict measures have been taken to ensure it is not sold until the inquiry is complete.
The committee formed by the Punjab government is investigating whether the issue is related to sterilization or if there is a problem with the entire batch. They are also examining the import license, distribution process, and the qualifications of the doctors who administered the injections. The investigation will determine the exact number of affected patients and the possible sources of contamination.
Doctors involved in the case have expressed their concerns and highlighted the need for attention to prevent such incidents in the future. Dr Asim Gill, who administered the injections, stated that Avastin is normally used to restore vision damaged by diabetes. However, in this case, multiple individuals lost their eyesight after receiving the injections. Mayo Hospital head surgeon Prof Asad Islam also reported blindness in patients who received the injections.
The Punjab government is committed to addressing this issue promptly and ensuring that the affected patients receive the necessary treatment and support.